Fanconi Anemia Complementation Group A Protein
"Fanconi Anemia Complementation Group A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A Fanconi anemia complementation group protein that is the most commonly mutated protein in FANCONI ANEMIA. It undergoes PHOSPHORYLATION by PROTEIN KINASE B and forms a complex with FANCC PROTEIN in the CELL NUCLEUS.
| Descriptor ID |
D052217
|
| MeSH Number(s) |
D12.776.313.500 D12.776.660.264 D12.776.744.476
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fanconi Anemia Complementation Group A Protein".
Below are MeSH descriptors whose meaning is more specific than "Fanconi Anemia Complementation Group A Protein".
This graph shows the total number of publications written about "Fanconi Anemia Complementation Group A Protein" by people in this website by year, and whether "Fanconi Anemia Complementation Group A Protein" was a major or minor topic of these publications.
Below are the most recent publications written about "Fanconi Anemia Complementation Group A Protein" by people in Profiles.
-
Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant. Cold Spring Harb Mol Case Stud. 2020 12; 6(6).
-
Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia. Genomics. 2020 11; 112(6):4628-4639.
-
Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A. Haematologica. 2018 11; 103(11):1806-1814.
-
Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48. Nat Commun. 2018 06 11; 9(1):2280.
-
Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun. 2014 Jul 07; 5:4330.
-
Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 2013 May 30; 121(22):e138-48.
-
The fanconi anemia pathway limits human papillomavirus replication. J Virol. 2012 Aug; 86(15):8131-8.
-
Overcoming reprogramming resistance of Fanconi anemia cells. Blood. 2012 Jun 07; 119(23):5449-57.
-
Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther. 2012 Feb; 23(2):141-4.
-
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther. 2010 Oct; 17(10):1244-52.